Table 5.
Genotypes of 159 thalassemia intermedia patients in the current study.
| Genotypes | Frequency | Percent |
|---|---|---|
| β 0/β0 | ||
| (1) IVS II.1/IVS II.1 | 57 | 35.9 |
| (2) IVS II.1/Cod 8/9 | 5 | 3.2 |
| (3) IVS II.1/IVS I.1 | 4 | 2.5 |
| (4) IVS II.1/Cod 8 | 4 | 2.5 |
| (5) Cod 8/9/Cod 8 | 3 | 1.9 |
| (6) Cod 8/Cod 8 | 2 | 1.3 |
| (7) IVS I.1/Cod 8 | 2 | 1.3 |
| (8) IVS II.1/Cod 5 | 2 | 1.3 |
| (9) IVS II.1/Cod 36/37 | 2 | 1.3 |
| (10) IVS II.1/Cod 39 | 2 | 1.3 |
| (11) IVS I.1/IVS I.1 | 2 | 1.3 |
| (12) Cod 5/Cod 5 | 1 | 0.6 |
| (13) IVS II.1/Cod 15 | 1 | 0.6 |
| (14) IVS II.1/Cod 82-83 | 1 | 0.6 |
| (15) Cod 44/Cod 44 | 1 | 0.6 |
| β +/β+ | ||
| (1) IVS I.6/IVS I.6 | 30 | 18.9 |
| (2) IVS I.110/IVS I.110 | 4 | 2.5 |
| (3) IVS I.128/IVS I.128 | 2 | 1.3 |
| (4) IVS I.110/IVS I.128 | 1 | 0.6 |
| (5) IVS I.6/IVS II.745 | 1 | 0.6 |
| β 0/β+ | ||
| (1) IVS II.1/IVS I.6 | 7 | 4.4 |
| (2) IVS II.1/IVS I.110 | 4 | 2.5 |
| (3) Cod 5/IVS I.128 | 2 | 1.3 |
| (4) IVS I.1/IVS I.6 | 2 | 1.3 |
| (5) Cod 8/9/IVS I.110 | 2 | 1.3 |
| (6) IVS I.1/CAP +1 | 2 | 1.3 |
| (7) Cod 8/IVS I.6 | 1 | 0.6 |
| (8) IVS II.1/IVS I.5 | 1 | 0.6 |
| (9) Cod 8/9/IVS I.6 | 1 | 0.6 |
| (10) Cod 39/IVS I.6 | 1 | 0.6 |
| (11) IVS II.850/IVS I.6 | 1 | 0.6 |
| (12) Cod 8/IVS I.110 | 1 | 0.6 |
| (13) IVS II.1/IVS I.128 | 1 | 0.6 |
| (14) IVS I.1/-101 | 1 | 0.6 |
| β 0/wt IVS II.1/wt (αααanti3.7) | 2 | 1.25 |
| β +/wt +20, IVS II.745/wt | 2 | 1.25 |
| Dominant like β-thalassemia Cod 127/wt |
1 | 0.6 |